Recombinant Thrombin Market to Witness a Pronounce Growth by 2025
Recombinant thrombin is a serine protease coagulant, produced in vitro by use of RDT also known as recombinant DNA technology. This recombinant thrombin shares an indistinguishable analogous structure and amino acid sequence with the human protein. Recombinant thrombin is specified for topical use to aid hemostasis in patients undergoing different surgeries, and is a potential hemostatic alternative to bovine and human plasma-derived thrombin. A recombinant thrombin offers a homologous protein that is effective and safe, but without the associated concerns of viral transmission or antibody production.
Request a brochure of this report -
It is used topically to achieve hemostasis at reachable sites of oozing blood and slight bleeding from small venules and capillaries when control of bleeding using standard surgical measures such as ligature, suture, electrocautery, etc. is impractical or ineffective. Recombinant thrombin can be used in combination with an absorbable gelatin sponge in different types of surgeries such as liver resection, spinal surgery, and peripheral arterial bypass surgery. Recombinant thrombin precursor that is secreted to culture medium in the form of single chain. This single chain is proteolytically transformed into a two-chain active form by using a protein derived from snakes. This active form is then purified by a chromatographic process which yields a product with hemostatic properties similar to native human thrombin.
The usage of bovine thrombin generates antibodies which cross react with human coagulation protein. This has resulted in severe complications and life threatening bleeding. Human thrombin was introduced as an alternative to bovine thrombin; however, it is associated with risk of viral transmission of infection. Nevertheless, recombinant thrombin is expected to gain popularity as it is devoid of risks associated with viral infection and has potential efficacy. Recombinant thrombin is also used in diagnostic centers and clinics in various applications such as clotting factor tests, coagulation assays, and defibrination of blood or plasma. R&D applications of thrombin includes several research activities such as in vitro study, coagulation research, protein-structure analysis, medical research, and biochemical research.
Request a ToC of this report -
Increase in number of surgeries worldwide, need for perioperative hemostasis, improved educational & awareness programs, rising investments in research & development of proteins as well as hemostasis, and increased demand for recombinant thrombin for research & diagnostic applications are anticipated to drive the growth of the global recombinant thrombin market. However, recombinant thrombin also has certain limitations such as thromboembolic adverse reactions in some patients, and antibody formation in others. These restraints may limit the growth of the market. The global recombinant thrombin market has been segmented based on applications, end-user, and region. Based on applications, the market has been segmented into therapeutic, surgical, and research & diagnostics. Based on end-user, the market has been segmented into hospitals, diagnostic centers, and academic & research institutes.
Geographically, the global recombinant thrombin market has been segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America holds the largest market share, while Europe holds the second-largest share. High demand for recombinant thrombin due to increased number of surgeries in North America and Europe has put these regions into leading positions.
Recothrom is the only approved brand of recombinant thrombin in the U.S. Recothrom is available in powder form which is used topically by making solution. Recothrom was originally invented and manufactured by ZymoGenetics, and was then owned & marketed by Mallinckrodt Pharmaceuticals in the U.S. Recently Mallinckrodt Pharmaceuticals sold Recothrom to Baxter International Inc.
View Report -
Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants, use proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.
US Office Contact
90 State Street, Suite 700
Albany, NY 12207
USA – Canada Toll Free: 866-552-3453
This release was published on openPR.
Permanent link to this press release:
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Recombinant Thrombin Market to Witness a Pronounce Growth by 2025 here
News-ID: 959794 • Views: 165
More Releases from Transparency Market Research
Pad Printing Machine Market - Provides Veritable Information on Size, Growth Tre …
Pad Printing Machine Market: An Overview Need for an effective printing machine which can lay down simple one colored image or complex multicolor graphics to about every object helped in the introduction of pad printing machine. It is used to transfer a 2-D image via a silicon padon to a 3-D object on any type of surface like flat, spherical, irregular or cylindrical. Pad printing machine also prints photos or other
Varnished Cambric Tape Market - Company Strategy, Product Portfolio and Recent D …
Varnished cambric tape Market: An Overview The growth of renewable power generation will be an elementary factor to push the demand for the electrical wires and cables market across the globe, the countries are focusing more on power generation through renewable resources available in comparison with conventional (coal, thermal, etc.) power generation methodology, the transmission and distribution of electrical infrastructure is not only required to be completely developed in developed economies
Hip Flask Market | Reporting and Evaluation of Recent Industry Developments & Bu …
Hip Flask Market: An Overview Similar to the mobile, the hip flask started to appear in the form it was recognized today in the 18th century, the primarily hip flask was mainly used by the well-born people of high social class especially in the past. Initially, the hip flask was made of malleable metal alloy (Pewter), silver, gold, copper, and glass, but nowadays hip flask is also available in stainless steel
Cargo Pit Tape Market - Research Forecast, Revenue Opportunities And Sales Volum …
Cargo Pit Tape Market: An Overview The most important element in packaging is quality of adhesive to be used in packaged items to maintain the same quality throughout the supply chain till the time it reaches the destination safely. There are many types of packaging tapes available in the market with different applications. Polypropylene Tape: it’s economical, durable, and reliable and resistant to breaking or tearing during the shipping. Printed Fragile Tape: It
More Releases for Recombinant
Global Recombinant Factor VIII Market Research Report
This report studies the global Recombinant Factor VIII market status and forecast, categorizes the global Recombinant Factor VIII market size (value & volume) by manufacturers, type, application, and region. This report focuses on the top manufacturers in North America, Europe, Japan, China, and other regions (India, Southeast Asia). The major manufacturers covered in this report Shire (Baxter) Bayer CSL Pfizer Biogen Octapharma NovoNordisk Geographically, this report studies the top producers
United States Recombinant Vaccine Market Report
In this report, the United States Recombinant Vaccine market is valued at USD XX million in 2017 and is expected to reach USD XX million by the end of 2025, growing at a CAGR of XX% between 2017 and 2025. Geographically, this report splits the United States market into seven regions: The West Southwest The Middle Atlantic New England The South The Midwest with sales (volume), revenue (value), market share
Recombinant DNA Technology Market -
Recombinant DNA technology has allowed the transfer of desired characteristics which is useful to improve the existing systems by controlling expression of target genes. Recombinant DNA technology allows mass production of therapeutic proteins, which are characterized by high level of consistency and stability. The technology has multidisciplinary applications and potential to deal with important aspects of life, for instance, improving health, and enhancing food resources. The genetically modified plants have
Global Human Recombinant Insulin Market – Industry Insights
Discovery of insulin is considered to be one of the most important events in the history of the diabetes treatment. Furthermore, major advances in human insulin technology is the synthesis of human insulin analogue by recombinant technology. Currently, human insulin delivery system available for the administration of insulin include insulin syringes, insulin pumps, jet injections, and pens. Key players are focused on developing recombinant human insulin instead of animal-based insulin,
Global Human Recombinant Insulin Market – Industry Insights
Various government and private research organizations are engaged research and development activities for developing advanced treatment in diabetes care to increase the effectiveness of human insulin, reduce diabetes burden, and minimize the risk of diabetes associated disorders such as diabetes-associated blindness, kidney disease, heart attacks, strokes or limb loss. For instance, American Diabetes Association (ADA) invested US$ 807.4 million in more than 4,700 research projects in diabetes research since 1952
Recombinant Vaccines Market Industry Forecast till 2025
Recombinant vaccines are produced by using recombinant DNA technology or genetic engineering for the prevention of lethal diseases in human beings and animals. Recombinant vaccine is a biological preparation that provides active acquired immunity against a certain disease. Whereas individual being vaccinated produces antibodies against the protein antigen that protect a person from contracting the disease upon attack from the pathogenic microorganism. These vaccines functions on the immune response for